Reducing end xylose-releasing exo-oligoxylanase

BE0003069ProteinBacillus halodurans (strain ATCC BAA-125 / DSM 18197 / FERM 7344 / JCM 9153 / C-125)

Hydrolyzes xylooligosaccharides with a degree of polymerization of greater than or equal to 3, releasing xylose from the reducing end. It is acted on by 1 drug in DrugBank.

UniProtKB entry
Q9KB30Swiss-Prot
Cellular location
Cytoplasmic
Residues / weight
388 residues · 45,010 Da
Also known as
3.2.1.156 · Rex

Resolves to

Protein
UniProtQ9KB30UniProt nameREOX_HALH5
Pharmacology
KEGGbha:BH2105
Structure
PDB1WU4PDB1WU5PDB1WU6
Drugs

What you can answer from here — as of September 07, 2019

1DrugApproved to experimental, with action, bond type and pharmacological action
Sign in
2GO termsFunction, process and component, as structured annotations
Sign in
1Pfam domainDomain architecture mapped to Pfam families and clans
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which compounds in development act on Reducing end xylose-releasing exo-oligoxylanase, and which indications are they being tested in?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In